Vesugen (KED) – 20mg | Research Compound

Vesugen – 20mg | Research Compound

Vesugen is a synthetic tripeptide with the amino acid sequence Lys-Glu-Asp (KED), developed within the Khavinson peptide research program. It is studied in laboratory settings for its molecular characteristics, gene-expression interactions, and related cellular regulatory pathways.

Key Research Areas:

• Gene-Expression Research — Laboratory investigation of Vesugen-associated gene-expression patterns and molecular regulatory processes.
• Cellular Signaling Research — Laboratory characterization of molecular and cellular signaling associated with Vesugen.
• Short-Chain Peptide Research — Investigation of the molecular characteristics and activity of the KED tripeptide sequence.
• Comparative Peptide Research — Comparative investigation of Vesugen and structurally related short-chain peptide bioregulators.

Product Specifications:

• Sequence: Lys-Glu-Asp (KED)
• 20mg lyophilized research compound per vial
• ≥99% purity via HPLC
• Third-party COA available
• Store under appropriate controlled laboratory conditions and protect from light and moisture

For laboratory and research use only. Not intended for human or animal consumption, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic.